| Overview |
| bs-3102R-PE-Cy7 |
| DOK2 (Tyr299) Polyclonal Antibody, PE-Cy7 Conjugated |
| WB |
| Human, Dog, Pig, Horse |
| Specifications |
| PE-Cy7 |
| Rabbit |
| KLH conjugated synthetic phosphopeptide derived from human p56Dok2 around the phosphorylation site of Tyr299 |
| Tyr299 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 9046 |
| Cytoplasm |
| Docking protein 2 56kDa; Docking protein 2 antibody DOK 2; DOK R; Downstream of tyrosine kinase 2; p56dok 2; p56dok 2; p56DOK; p56dok2; DOK2; DOK2_HUMAN; Downstream of tyrosine kinase 2; OTTHUMP00000161710; OTTHUMP00000224923; p56dok 2; p56dok-2. |
| The protein encoded by this gene is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. This encoded protein binds p120 (RasGAP) from CML cells. [provided by RefSeq, Jul 2008] |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz